Respondent Categorization and Region | Number of Respondents | Number of Respondents |
---|---|---|
Advocacy Organization | 2 | 2% |
 Africa | 2 | 100% |
Implementer / Clinician | 53 | 51% |
 Africa | 32 | 60% |
 Asia | 1 | 2% |
 Europe | 2 | 4% |
 North America | 15 | 28% |
 Oceania | 3 | 6% |
Industry | 5 | 5% |
 Africa | 1 | 20% |
 Europe | 3 | 60% |
 North America | 1 | 20% |
International Body | 2 | 2% |
 Africa | 1 | 50% |
 Europe | 1 | 50% |
Ministry of Health | 5 | 5% |
 Africa | 4 | 80% |
 North America | 1 | 20% |
Other | 21 | 20% |
 Africa | 8 | 38% |
 Europe | 4 | 19% |
 North America | 8 | 38% |
 Oceania | 1 | 5% |
Technical Agency / Researcher | 15 | 15% |
 Africa | 4 | 27% |
 Europe | 2 | 13% |
 North America | 7 | 47% |
 Oceania | 2 | 13% |
Funders | 0 | 0% |